Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2013 May 16;12(8):1638–1650. doi: 10.1158/1535-7163.MCT-13-0047
Strong: Mean binding affinity is > 10%; the site can bind to all five C/EBP isoforms.
Moderate: Mean binding affinity is at least 2%; the site can bind to 4 or more isoforms.
Weak: Mean binding affinity is less than 2%; the site can bind to at least 2 isoforms.
Non-binding The site fails to bind to any of the C/EBP isoforms.